Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in from biologics discovery and development through to production and supply chain management.

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Vaccines

Vaccine Production for Better Global Access

How were the COVID-19 vaccines developed so fast? And why were some countries left behind?
Read More
Vaccines

Pioneers of COVID-19 mRNA Vaccine Win Nobel Prize

Professors Katalin Karikó and Drew Weissman have been awarded the 2023 Nobel Prize in Medicine for their contributions to the development of the COVID-19 mRNA vaccine.
Read More
Proteins & Antibodies

FDA Approves Takeda’s Subcutaneous Ulcerative Colitis mAb

The company can now sell their biologic for ulcerative colitis in a subcutaneous form on the US market.
Read More
Proteins & Antibodies

Navigating the Pharma R&D Regulatory Landscape 2023

Our ‘Navigating the Regulatory Landscape’ eBook has been designed to provide you with invaluable insights into the intricacies of regulations & policies surrounding the challenges and opportunities of Real-World Data, genome editing, biomedical informatics, manufacturing and many more.
Read More
Oligonucleotides

How Do Regulatory Considerations Impact the Clinical Development of Oligonucleotide Therapies?

What are the regulatory considerations that need to be made in the clinic for oligonucleotide therapies? What's the existing guidance for this emerging modality?
Read More
Peptides

Trends and Challenges in Peptide Bioanalysis and Production

Here, we investigate some of the main trends and challenges in peptide bioanalysis such as non-specific binding, and look at how they can be circumvented.
Read More
Oligonucleotides

Revolutionizing Biologics: Unveiling the Challenges and Innovations in Large-Scale Oligonucleotide Synthesis 

Read More
Proteins & Antibodies

Amgen and Synaffix Pen $2 Billion

Amgen and Synaffix's partnership aims to revolutionise cancer treatment by developing highly targeted antibody-drug conjugates (ADCs).
Read More
Oligonucleotides

Assessment of Long IVT mRNA Fragments with the Aligent Fragment Analyzer Systems

Read More
Oligonucleotides

Early Formulation Screening with Merck

Read More
Oligonucleotides

Early-Stage Development of LNP Formulations

Read More
Oligonucleotides

Friedrich Miescher: The Pioneer of Nucleic Acid Discovery

As medical research that is founded on nucleic acids continues to progress, we take a step back to look at the man who first discovered nucleic acids.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biologics